Iovance Biotherapeutics, Inc.
EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF
Last updated:
Abstract:
Methods of expanding tumor infiltrating lymphocytes (TILs) using a potassium channel agonist, such as a K.sub.Ca3.1 (IK channel) agonist, and uses of such expanded TILs in the treatment of diseases such as cancer are disclosed herein.
Status:
Application
Type:
Utility
Filling date:
5 Jan 2018
Issue date:
12 Dec 2019